Localized Delivery of Bioactives using Structured Liposomal Gels

Deepak      Kumar; Kamal      Dua; Sanjay      Tiwari
Abstract

Liposomes have gained a lot of interest for drug delivery applications, and some of these preparations have been commercialized. These are formulated with biocompatible components and can be used for delivering a wide range of payloads differing in aqueous solubility and molecular weight. Liposome-based delivery approaches are limited mainly by two factors: (a) poor dispersion stability, and (b) pre-mature leakage of payloads. In this review, we have discussed the stabilization of liposomal vesicles by their entrapment in hydrogels. Studies reveal that such hydrogels can maintain the structural integrity of liposomes. Release of liposomes from the hydrogel network can be modulated through careful screening of matrix former and degree of its cross-linking. Accordingly, we have reviewed the approaches of stabilizing liposomal vesicles through entrapment in hydrogels. Application of liposome-embedded hydrogels has been reviewed in context of localized drug delivery. Our discussion is focussed on the delivery of bioactives to the skin. Such an approach appears alluring from the standpoint of minimizing the undesirable distribution of payload(s) the systemic circulation and off-target sites.
[1]
Nkanga CI, Krause RW, Noundou XS, Walker RB. Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes. Int J Pharm  2017; 526(1-2): 466-73.
 [http://dx.doi.org/10.1016/j.ijpharm.2017.04.074] [PMID: 28461265]

[2]
Goldmann O, Cern A, Müsken M, et al. Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections. J Control Release  2019; 316: 292-301.
 [http://dx.doi.org/10.1016/j.jconrel.2019.11.007] [PMID: 31715276]

[3]
Bavli Y, Winkler I, Chen BM, et al. Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs. J Control Release  2019; 306: 138-48.
 [http://dx.doi.org/10.1016/j.jconrel.2019.06.007] [PMID: 31176656]

[4]
Guillot AJ, Merino-Gutiérrez P, Bocchino A, et al. Exploration of microneedle-assisted skin delivery of cyanocobalamin formulated in ultraflexible lipid vesicles. Eur J Pharm Biopharm  2022; 177: 184-98.
 [http://dx.doi.org/10.1016/j.ejpb.2022.06.015] [PMID: 35787430]

[5]
Charankumar K, Bagasariya D, Jain N, et al. Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma. J Drug Deliv Sci Technol  2023; 84: 104453.
 [http://dx.doi.org/10.1016/j.jddst.2023.104453]

[6]
Lamparelli EP, Ciardulli MC, Scala P, et al. Lipid nano-vesicles for thyroid hormone encapsulation: A comparison between different fabrication technologies, drug loading, and an in vitro delivery to human tendon stem/progenitor cells in 2D and 3D culture. Int J Pharm  2022; 624: 122007.
 [http://dx.doi.org/10.1016/j.ijpharm.2022.122007] [PMID: 35820518]

[7]
Yu Y, Anthony SM, Bae SC, Granick S. How liposomes diffuse in concentrated liposome suspensions. J Phys Chem B  2011; 115(12): 2748-53.
 [http://dx.doi.org/10.1021/jp109146s] [PMID: 21384815]

[8]
Liu Y, Liu J. Growing a nucleotide/lanthanide coordination polymer shell on liposomes. Langmuir  2019; 35(34): 11217-24.
 [http://dx.doi.org/10.1021/acs.langmuir.9b00677] [PMID: 31379173]

[9]
Khan MS, Mohapatra S, Gupta V, et al. Potential of lipid-based nanocarriers against two major barriers to drug delivery and blood brain barrier. Membranes  2023; 13(3): 343.
 [http://dx.doi.org/10.3390/membranes13030343] [PMID: 36984730]

[10]
MacKinnon N, Guérin G, Liu B, Gradinaru CC, Rubinstein JL, Macdonald PM. Triggered instability of liposomes bound to hydrophobically modified core-shell PNIPAM hydrogel beads. Langmuir  2010; 26(2): 1081-9.
 [http://dx.doi.org/10.1021/la902423v] [PMID: 19754070]

[11]
Furlani F, Rossi A, Grimaudo MA, et al. Controlled liposome delivery from chitosan-based thermosensitive hydrogel for regenerative medicine. Int J Mol Sci  2022; 23(2): 894.
 [http://dx.doi.org/10.3390/ijms23020894] [PMID: 35055097]

[12]
Reginald-Opara JN, Tang M, Svirskis D, Chamley L, Wu Z. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier. Int J Pharm  2022; 626: 122152.
 [http://dx.doi.org/10.1016/j.ijpharm.2022.122152] [PMID: 36055442]

[13]
Chen H, Pan H, Li P, et al. The potential use of novel chitosan- coated deformable liposomes in an ocular drug delivery system. Colloids Surf B Biointerfaces  2016; 143: 455-62.
 [http://dx.doi.org/10.1016/j.colsurfb.2016.03.061] [PMID: 27037783]

[14]
Kumar D, Suna A, Ray D, Aswal VK, Bahadur P, Tiwari S. Structural changes in liposomal vesicles in association with sodium taurodeoxycholate. AAPS PharmSciTech  2023; 24(4): 95.
 [http://dx.doi.org/10.1208/s12249-023-02550-7] [PMID: 37012522]

[15]
Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery. Int J Pharm  2006; 322(1-2): 60-6.
 [http://dx.doi.org/10.1016/j.ijpharm.2006.05.027] [PMID: 16806755]

[16]
Maestrelli F, González-Rodríguez ML, Rabasco AM, Ghelardini C, Mura P. New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm  2010; 395(1-2): 222-31.
 [http://dx.doi.org/10.1016/j.ijpharm.2010.05.046] [PMID: 20594944]

[17]
Laomeephol C, Ferreira H, Kanokpanont S, Neves NM, Kobayashi H, Damrongsakkul S. Dual-functional liposomes for curcumin delivery and accelerating silk fibroin hydrogel formation. Int J Pharm  2020; 589: 119844.
 [http://dx.doi.org/10.1016/j.ijpharm.2020.119844] [PMID: 32905796]

[18]
Tan C, Xia S, Xue J, Xie J, Feng B, Zhang X. Liposomes as vehicles for lutein: Preparation, stability, liposomal membrane dynamics, and structure. J Agric Food Chem  2013; 61(34): 8175-84.
 [http://dx.doi.org/10.1021/jf402085f] [PMID: 23906192]

[19]
Petralito S, Paolicelli P, Nardoni M, et al. Gelation of the internal core of liposomes as a strategy for stabilization and modified drug delivery II. Theoretical analysis and modelling of in-vitro release experiments. Int J Pharm  2020; 585: 119471.
 [http://dx.doi.org/10.1016/j.ijpharm.2020.119471] [PMID: 32479896]

[20]
Pitorre M, Gondé H, Haury C, et al. Recent advances in nanocarrier-loaded gels: Which drug delivery technologies against which diseases? J Control Release  2017; 266: 140-55.
 [http://dx.doi.org/10.1016/j.jconrel.2017.09.031] [PMID: 28951319]

[21]
Li Y, Xu F, Li X, et al. Development of curcumin-loaded composite phospholipid ethosomes for enhanced skin permeability and vesicle stability. Int J Pharm  2021; 592: 119936.
 [http://dx.doi.org/10.1016/j.ijpharm.2020.119936] [PMID: 33038455]

[22]
Liu L, Xiang Y, Wang Z, et al. Adhesive liposomes loaded onto an injectable, self-healing and antibacterial hydrogel for promoting bone reconstruction. NPG Asia Mater  2019; 11(1): 81.
 [http://dx.doi.org/10.1038/s41427-019-0185-z]

[23]
Li D, An X, Mu Y. A liposomal hydrogel with enzyme triggered release for infected wound. Chem Phys Lipids  2019; 223: 104783.
 [http://dx.doi.org/10.1016/j.chemphyslip.2019.104783] [PMID: 31233714]

[24]
Zhang J, Yan J, Pageni P, et al. Anion-responsive metallopolymer hydrogels for healthcare applications. Sci Rep  2015; 5(1): 11914.
 [http://dx.doi.org/10.1038/srep11914] [PMID: 26202475]

[25]
Ciobanu BC, Cadinoiu AN, Popa M, Desbrières J, Peptu CA. Modulated release from liposomes entrapped in chitosan/gelatin hydrogels. Mater Sci Eng C  2014; 43: 383-91.
 [http://dx.doi.org/10.1016/j.msec.2014.07.036] [PMID: 25175227]

[26]
Hurler J, Berg OA, Skar M, Conradi AH, Johnsen PJ, Škalko-Basnet N. Improved burns therapy: Liposomes-in-hydrogel delivery system for mupirocin. J Pharm Sci  2012; 101(10): 3906-15.
 [http://dx.doi.org/10.1002/jps.23260] [PMID: 22777770]

[27]
Zhang ZJ, Osmałek T, Michniak-Kohn B. Deformable liposomal hydrogel for dermal and transdermal delivery of meloxicam. Int J Nanomedicine  2020; 15: 9319-35.
 [http://dx.doi.org/10.2147/IJN.S274954] [PMID: 33262590]

[28]
Li R, Lin Z, Zhang Q, et al. Injectable and in situ-formable thiolated chitosan-coated liposomal hydrogels as curcumin carriers for prevention of in vivo  breast cancer recurrence. ACS Appl Mater Interfaces  2020; 12(15): 17936-48.
 [http://dx.doi.org/10.1021/acsami.9b21528] [PMID: 32208630]

[29]
An YH, Lee J, Son DU, et al. Facilitated transdermal drug delivery using nanocarriers-embedded electroconductive hydrogel coupled with reverse electrodialysis-driven iontophoresis. ACS Nano  2020; 14(4): 4523-35.
 [http://dx.doi.org/10.1021/acsnano.0c00007] [PMID: 32191436]

[30]
Hua S. Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. Int J Nanomedicine  2014; 9: 735-44.
 [http://dx.doi.org/10.2147/IJN.S55805] [PMID: 24511230]

[31]
Fernández-García R, Statts L, de Jesus JA, et al. Ultradeformable lipid vesicles localize amphotericin B in the dermis for the treatment of infectious skin diseases. ACS Infect Dis  2020; 6(10): 2647-60.
 [http://dx.doi.org/10.1021/acsinfecdis.0c00293] [PMID: 32810398]

[32]
Tian L, Wang X, Qi J, et al. Improvement of the surface wettability of silicone hydrogel films by self-assembled hydroxypropyltrimethyl ammonium chloride chitosan mixed colloids. Colloids Surf A Physicochem Eng Asp  2018; 558: 422-8.
 [http://dx.doi.org/10.1016/j.colsurfa.2018.08.073]

[33]
Petralito S, Paolicelli P, Nardoni M, et al. Gelation of the internal core of liposomes as a strategy for stabilization and modified drug delivery I. Physico-chemistry study. Int J Pharm  2020; 585: 119467.
 [http://dx.doi.org/10.1016/j.ijpharm.2020.119467] [PMID: 32497730]

[34]
Tiwari S, Goyal AK, Mishra N, et al. Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Control Release  2009; 140(2): 157-65.
 [http://dx.doi.org/10.1016/j.jconrel.2009.08.004] [PMID: 19686788]

[35]
Torres-Martínez A, Angulo-Pachón CA, Galindo F, Miravet JF. Liposome-enveloped molecular nanogels. Langmuir  2019; 35(41): 13375-81.
 [http://dx.doi.org/10.1021/acs.langmuir.9b02282] [PMID: 31549515]

[36]
Kawar D, Abdelkader H. Hyaluronic acid gel-core liposomes (hyaluosomes) enhance skin permeation of ketoprofen. Pharm Dev Technol  2019; 24(8): 947-53.
 [http://dx.doi.org/10.1080/10837450.2019.1572761] [PMID: 30676142]

[37]
Friggeri A, Feringa BL, van Esch J. Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator. J Control Release  2004; 97(2): 241-8.
 [http://dx.doi.org/10.1016/j.jconrel.2004.03.012] [PMID: 15196751]

[38]
Heeres A, van der Pol C, Stuart M, Friggeri A, Feringa BL, van Esch J. Orthogonal self-assembly of low molecular weight hydrogelators and surfactants. J Am Chem Soc  2003; 125(47): 14252-3.
 [http://dx.doi.org/10.1021/ja036954h] [PMID: 14624554]

[39]
Mandegani F, Zali-Boeini H, Khayat Z, Braun JD, Herbert DE. Low-molecular-weight gelators as dual-responsive chemosensors for the naked-eye detection of mercury (II) and copper (II) ions and molecular logic gates. ChemistrySelect  2020; 5(2): 886-93.
 [http://dx.doi.org/10.1002/slct.201903436]

[40]
Cheng CY, Wang TY, Tung SH. Biological hydrogels formed by swollen multilamellar liposomes. Langmuir  2015; 31(49): 13312-20.
 [http://dx.doi.org/10.1021/acs.langmuir.5b03267] [PMID: 26574777]

[41]
Štaka I, Cadete A, Surikutchi BT, et al. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs. Int J Pharm  2019; 565: 151-61.
 [http://dx.doi.org/10.1016/j.ijpharm.2019.04.070] [PMID: 31029659]

[42]
Boekhoven J, Brizard AM, Stuart MCA, et al. Bio-inspired supramolecular materials by orthogonal self-assembly of hydrogelators and phospholipids. Chem Sci  2016; 7(9): 6021-31.
 [http://dx.doi.org/10.1039/C6SC01021K] [PMID: 30034743]

[43]
Raymond DM, Abraham BL, Fujita T, et al. Low-molecular-weight supramolecular hydrogels for sustained and localized in vivo  drug delivery. ACS Appl Bio Mater  2019; 2(5): 2116-24.
 [http://dx.doi.org/10.1021/acsabm.9b00125] [PMID: 34136760]

[44]
Khan MA, Ghosh S, Bera S, et al. Crystallographic elucidation of stimuli-controlled molecular rotation for a reversible sol–gel transformation. J Org Chem  2020; 85(6): 4019-25.
 [http://dx.doi.org/10.1021/acs.joc.9b02944] [PMID: 32077292]

[45]
Boekhoven J, Koot M, Wezendonk TA, Eelkema R, van Esch JH. A self-assembled delivery platform with post-production tunable release rate. J Am Chem Soc  2012; 134(31): 12908-11.
 [http://dx.doi.org/10.1021/ja3051876] [PMID: 22823592]

[46]
Wang Y, Xu Z, Lovrak M, et al. Biomimetic strain-stiffening self- assembled hydrogels. Angew Chem Int Ed  2020; 59(12): 4830-4.
 [http://dx.doi.org/10.1002/anie.201911364] [PMID: 31912568]

[47]
Zhao C, Wang Y, Shi B, Li M, Yan W, Yang H. Tailoring co-assembly loading of doxorubicin in solvent-triggering gel. J Colloid Interface Sci  2022; 626: 619-28.
 [http://dx.doi.org/10.1016/j.jcis.2022.06.175] [PMID: 35810701]

[48]
Veloso SRS, Tiryaki E, Spuch C, et al. Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels. Nanoscale  2022; 14(14): 5488-500.
 [http://dx.doi.org/10.1039/D1NR08158F] [PMID: 35332904]

[49]
Veloso SRS, Gomes V, Mendes SLF, et al. Plasmonic lipogels: Driving co-assembly of composites with peptide-based gels for controlled drug release. Soft Matter  2022; 18(44): 8384-97.
 [http://dx.doi.org/10.1039/D2SM00926A] [PMID: 36193825]

[50]
Mura P, Mennini N, Nativi C, Richichi B. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. Eur J Pharm Biopharm  2018; 122: 54-61.
 [http://dx.doi.org/10.1016/j.ejpb.2017.10.008] [PMID: 29032194]

[51]
Lajavardi L, Camelo S, Agnely F, et al. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. J Control Release  2009; 139(1): 22-30.
 [http://dx.doi.org/10.1016/j.jconrel.2009.05.033] [PMID: 19481575]

[52]
Lee JH, Oh H, Baxa U, Raghavan SR, Blumenthal R. Biopolymer-connected liposome networks as injectable biomaterials capable of sustained local drug delivery. Biomacromolecules  2012; 13(10): 3388-94.
 [http://dx.doi.org/10.1021/bm301143d] [PMID: 22970880]

[53]
Thompson BR, Zarket BC, Lauten EH, Amin S, Muthukrishnan S, Raghavan SR. Liposomes entrapped in biopolymer hydrogels can spontaneously release into the external solution. Langmuir  2020; 36(26): 7268-76.
 [http://dx.doi.org/10.1021/acs.langmuir.0c00596] [PMID: 32543183]

[54]
El Kechai N, Bochot A, Huang N, Nguyen Y, Ferrary E, Agnely F. Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs. Int J Pharm  2015; 487(1-2): 187-96.
 [http://dx.doi.org/10.1016/j.ijpharm.2015.04.019] [PMID: 25882015]

[55]
Liu W, Kong Y, Ye A, et al. Preparation, formation mechanism and in vitro dynamic digestion behavior of quercetin-loaded liposomes in hydrogels. Food Hydrocoll  2020; 104: 105743.
 [http://dx.doi.org/10.1016/j.foodhyd.2020.105743]

[56]
Mao Y, Li X, Chen G, Wang S. Thermosensitive hydrogel system with paclitaxel liposomes used in localized drug delivery system for in situ treatment of tumor: Better antitumor efficacy and lower toxicity. J Pharm Sci  2016; 105(1): 194-204.
 [http://dx.doi.org/10.1002/jps.24693] [PMID: 26580704]

[57]
O’Neill HS, Herron CC, Hastings CL, et al. A stimuli responsive liposome loaded hydrogel provides flexible on-demand release of therapeutic agents. Acta Biomater  2017; 48: 110-9.
 [http://dx.doi.org/10.1016/j.actbio.2016.10.001] [PMID: 27773752]

[58]
Popescu MT, Mourtas S, Pampalakis G, Antimisiaris SG, Tsitsilianis C. pH-responsive hydrogel/liposome soft nanocomposites for tuning drug release. Biomacromolecules  2011; 12(8): 3023-30.
 [http://dx.doi.org/10.1021/bm2006483] [PMID: 21728314]

[59]
Liu P, Guo B, Wang S, Ding J, Zhou W. A thermo-responsive and self-healing liposome-in-hydrogel system as an antitubercular drug carrier for localized bone tuberculosis therapy. Int J Pharm  2019; 558: 101-9.
 [http://dx.doi.org/10.1016/j.ijpharm.2018.12.083] [PMID: 30634030]

[60]
Grijalvo S, Mayr J, Eritja R, Díaz DD. Biodegradable liposome-encapsulated hydrogels for biomedical applications: A marriage of convenience. Biomater Sci  2016; 4(4): 555-74.
 [http://dx.doi.org/10.1039/C5BM00481K] [PMID: 26818789]

[61]
Ullrich M, Hanuš J, Dohnal J, Štěpánek F. Encapsulation stability and temperature-dependent release kinetics from hydrogel-immobilised liposomes. J Colloid Interface Sci  2013; 394: 380-5.
 [http://dx.doi.org/10.1016/j.jcis.2012.11.016] [PMID: 23276685]

[62]
Ma YH, Yang J, Li B, Jiang YW, Lu X, Chen Z. Biodegradable and injectable polymer–liposome hydrogel: A promising cell carrier. Polym Chem  2016; 7(11): 2037-44.
 [http://dx.doi.org/10.1039/C5PY01773D]

[63]
Ruel-Gariépy E, Leclair G, Hildgen P, Gupta A, Leroux JC. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release  2002; 82(2-3): 373-83.
 [http://dx.doi.org/10.1016/S0168-3659(02)00146-3] [PMID: 12175750]

[64]
Uhríková D, Kučerka N, Teixeira J, Gordeliy V, Balgavý P. Structural changes in dipalmitoylphosphatidylcholine bilayer promoted by Ca2+ ions: A small-angle neutron scattering study. Chem Phys Lipids  2008; 155(2): 80-9.
 [http://dx.doi.org/10.1016/j.chemphyslip.2008.07.010] [PMID: 18721799]

[65]
Akutsu H, Seelig J. Interaction of metal ions with phosphatidylcholine bilayer membranes. Biochemistry  1981; 20(26): 7366-73.
 [http://dx.doi.org/10.1021/bi00529a007] [PMID: 6895698]

[66]
Melcrová A, Pokorna S, Pullanchery S, et al. The complex nature of calcium cation interactions with phospholipid bilayers. Sci Rep  2016; 6(1): 38035.
 [http://dx.doi.org/10.1038/srep38035] [PMID: 27905555]

[67]
Pabst G, Hodzic A, Štrancar J, Danner S, Rappolt M, Laggner P. Rigidification of neutral lipid bilayers in the presence of salts. Biophys J  2007; 93(8): 2688-96.
 [http://dx.doi.org/10.1529/biophysj.107.112615] [PMID: 17586572]

[68]
De SK, Kanwa N, Chakraborty A. influence of trivalent metal ions on lipid vesicles: gelation and fusion phenomena. Langmuir  2019; 35(19): 6429-40.
 [http://dx.doi.org/10.1021/acs.langmuir.9b00682] [PMID: 30983360]

[69]
Binder H, Zschörnig O. The effect of metal cations on the phase behavior and hydration characteristics of phospholipid membranes. Chem Phys Lipids  2002; 115(1-2): 39-61.
 [http://dx.doi.org/10.1016/S0009-3084(02)00005-1] [PMID: 12047897]

[70]
Hasan MN, Salman MS, Hasan MM, et al. Assessing sustainable Lutetium(III) ions adsorption and recovery using novel composite hybrid nanomaterials. J Mol Struct  2023; 1276: 134795.
 [http://dx.doi.org/10.1016/j.molstruc.2022.134795]

[71]
Garidel P, Blume A, Hübner W. A Fourier transform infrared spectroscopic study of the interaction of alkaline earth cations with the negatively charged phospholipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol. Biochim Biophys Acta Biomembr  2000; 1466(1-2): 245-59.
 [http://dx.doi.org/10.1016/S0005-2736(00)00166-8] [PMID: 10825446]

[72]
Awual MR, Hasan MM, Khaleque MA, Sheikh MC. Treatment of copper(II) containing wastewater by a newly developed ligand based facial conjugate materials. Chem Eng J  2016; 288: 368-76.
 [http://dx.doi.org/10.1016/j.cej.2015.11.108]

[73]
Xiao X, Montaño GA, Edwards TL, et al. Surface charge dependent nanoparticle disruption and deposition of lipid bilayer assemblies. Langmuir  2012; 28(50): 17396-403.
 [http://dx.doi.org/10.1021/la303300b] [PMID: 23163515]

[74]
Wang B, Zhang L, Bae SC, Granick S. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci USA  2008; 105(47): 18171-5.
 [http://dx.doi.org/10.1073/pnas.0807296105] [PMID: 19011086]

[75]
Moriyama J, Yoshimoto M. Efficient entrapment of carbonic anhydrase in alginate hydrogels using liposomes for continuous-flow catalytic reactions. ACS Omega  2021; 6(9): 6368-78.
 [http://dx.doi.org/10.1021/acsomega.0c06299] [PMID: 33718727]

[76]
GuhaSarkar S, More P, Banerjee R. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery. J Control Release  2017; 245: 147-56.
 [http://dx.doi.org/10.1016/j.jconrel.2016.11.031] [PMID: 27913307]

[77]
Deng R, Derry MJ, Mable CJ, Ning Y, Armes SP. Using dynamic covalent chemistry to drive morphological transitions: Controlled release of encapsulated nanoparticles from block copolymer vesicles. J Am Chem Soc  2017; 139(22): 7616-23.
 [http://dx.doi.org/10.1021/jacs.7b02642] [PMID: 28497960]

[78]
Maiti C, Banerjee R, Maiti S, Dhara D. pH-induced vesicle-to-micelle transition in amphiphilic diblock copolymer: investigation by energy transfer between in situ formed polymer embedded gold nanoparticles and fluorescent dye. Langmuir  2015; 31(1): 32-41.
 [http://dx.doi.org/10.1021/la504165e] [PMID: 25494810]

[79]
Brown W, Schillen K, Almgren M, Hvidt S, Bahadur P. Micelle and gel formation in a poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) triblock copolymer in water solution: Dynamic and static light scattering and oscillatory shear measurements. J Phys Chem  1991; 95(4): 1850-8.
 [http://dx.doi.org/10.1021/j100157a064]

[80]
Hasan MM, Salman MS, Hasan MN, et al. Facial conjugate adsorbent for sustainable Pb(II) ion monitoring and removal from contaminated water. Colloids Surf A Physicochem Eng Asp  2023; 673: 131794.
 [http://dx.doi.org/10.1016/j.colsurfa.2023.131794]

[81]
Tiwari S, Singh K, Gerrard Marangoni D, Bahadur P. Amphiphilic star block copolymer micelles in saline as effective vehicle for quercetin solubilization. J Mol Liq  2022; 345: 118259.
 [http://dx.doi.org/10.1016/j.molliq.2021.118259]

[82]
Tiwari S, Kansara V, Bahadur P. Targeting anticancer drugs with pluronic aggregates: Recent updates. Int J Pharm  2020; 586: 119544.
 [http://dx.doi.org/10.1016/j.ijpharm.2020.119544] [PMID: 32561309]

[83]
Patidar P, Bahadur A, Prasad K, Tiwari S, Aswal VK, Bahadur P. Synthesis, self-assembly and micellization characteristics of choline alkanoate ionic liquids in association with a star block copolymer. Colloids Surf A Physicochem Eng Asp  2018; 555: 691-8.
 [http://dx.doi.org/10.1016/j.colsurfa.2018.08.002]

[84]
Wagh SS, Sarolia J, Patil YK, Aswal VK, Bahadur P, Tiwari S. Cooperative interaction of a highly hydrophilic pluronic with bile salts of different hydrophobicity. Colloids Surf A Physicochem Eng Asp  2023; 672: 131709.
 [http://dx.doi.org/10.1016/j.colsurfa.2023.131709]

[85]
Calori IR, Pinheiro L, Braga G, et al. Interaction of triblock copolymers (Pluronic®) with DMPC vesicles: A photophysical and computational study. Spectrochim Acta A Mol Biomol Spectrosc  2022; 275: 121178.
 [http://dx.doi.org/10.1016/j.saa.2022.121178] [PMID: 35366523]

[86]
Calori IR, Caetano W, Tedesco AC, Hioka N. Determination of critical micelle temperature of Pluronic® in Pluronic/gel phase liposome mixtures using steady-state anisotropy. J Mol Liq  2020; 304: 112784.
 [http://dx.doi.org/10.1016/j.molliq.2020.112784]

[87]
Chandaroy P, Sen A, Hui SW. Temperature-controlled content release from liposomes encapsulating Pluronic F127. J Control Release  2001; 76(1-2): 27-37.
 [http://dx.doi.org/10.1016/S0168-3659(01)00429-1] [PMID: 11532310]

[88]
Grassi G, Crevatin A, Farra R, et al. Rheological properties of aqueous Pluronic–alginate systems containing liposomes. J Colloid Interface Sci  2006; 301(1): 282-90.
 [http://dx.doi.org/10.1016/j.jcis.2006.04.068] [PMID: 16777132]

[89]
Liu Y, Li Z, Liang D. Behaviors of liposomes in a thermo-responsive poly(N-isopropylacrylamide) hydrogel. Soft Matter  2012; 8(16): 4517-23.
 [http://dx.doi.org/10.1039/c2sm25092f]

[90]
Wu H, Nan J, Yang L, Park HJ, Li J. Insulin-loaded liposomes packaged in alginate hydrogels promote the oral bioavailability of insulin. J Control Release  2023; 353: 51-62.
 [http://dx.doi.org/10.1016/j.jconrel.2022.11.032] [PMID: 36410613]

[91]
Alinaghi A, Rouini MR, Johari Daha F, Moghimi HR. The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles. Int J Pharm  2014; 459(1-2): 30-9.
 [http://dx.doi.org/10.1016/j.ijpharm.2013.11.011] [PMID: 24239579]

[92]
Sun Z, Song C, Wang C, Hu Y, Wu J. Hydrogel-based controlled drug delivery for cancer treatment: A review. Mol Pharm  2020; 17(2)
 [http://dx.doi.org/10.1021/acs.molpharmaceut.9b01020] [PMID: 31877054]

[93]
Gu D, Tan S, O’Connor AJ, Qiao GG. On-demand cascade release of hydrophobic chemotherapeutics from a multicomponent hydrogel system. ACS Biomater Sci Eng  2018; 4(5): 696-707.
 [http://dx.doi.org/10.1021/acsbiomaterials.8b00166] [PMID: 33445326]

[94]
Ni Y, Zhao W, Cheng W, et al. Lipopeptide liposomes-loaded hydrogel for multistage transdermal chemotherapy of melanoma. J Control Release  2022; 351: 245-54.
 [http://dx.doi.org/10.1016/j.jconrel.2022.09.014] [PMID: 36108811]

[95]
Zhao X, Ming H, Wang Y, et al. Mussel-inspired, injectable polyurethane tissue adhesives demonstrate in situ gel formation under mild conditions. ACS Appl Bio Mater  2021; 4(6): 5352-61.
 [http://dx.doi.org/10.1021/acsabm.1c00451] [PMID: 35007015]

[96]
Jangde R, Srivastava S, Singh MR, Singh D. In vitro and in vivo  characterization of quercetin loaded multiphase hydrogel for wound healing application. Int J Biol Macromol  2018; 115: 1211-7.
 [http://dx.doi.org/10.1016/j.ijbiomac.2018.05.010] [PMID: 29730004]

[97]
Kandregula B, Narisepalli S, Chitkara D, Mittal A. Exploration of lipid-based nanocarriers as drug delivery systems in diabetic foot ulcer. Mol Pharm  2022; 19(7): 1977-98.
 [http://dx.doi.org/10.1021/acs.molpharmaceut.1c00970] [PMID: 35481377]

[98]
Hamdan S, Pastar I, Drakulich S, et al. Nanotechnology-driven therapeutic interventions in wound healing: Potential uses and applications. ACS Cent Sci  2017; 3(3): 163-75.
 [http://dx.doi.org/10.1021/acscentsci.6b00371] [PMID: 28386594]

[99]
Pires F, Santos JF, Bitoque D, et al. Polycaprolactone/gelatin nanofiber membranes containing egcg-loaded liposomes and their potential use for skin regeneration. ACS Appl Bio Mater  2019; 2(11): 4790-800.
 [http://dx.doi.org/10.1021/acsabm.9b00524] [PMID: 35021479]

[100]
Aramwit P. 1-Introduction to biomaterials for wound healing. In: Ågren MS, Ed.  Wound Healing Biomaterials.  Woodhead Publishing 2016; pp. 3-38.

[101]
Li M, Liang Y, He J, Zhang H, Guo B. Two-pronged strategy of biomechanically active and biochemically multifunctional hydrogel wound dressing to accelerate wound closure and wound healing. Chem Mater  2020; 32(23): 9937-53.
 [http://dx.doi.org/10.1021/acs.chemmater.0c02823]

[102]
Xu Z, Han S, Gu Z, Wu J. Advances and impact of antioxidant hydrogel in chronic wound healing. Adv Healthc Mater  2020; 9(5): 1901502.
 [http://dx.doi.org/10.1002/adhm.201901502] [PMID: 31977162]

[103]
Marroquin-Garcia R, Royakkers J, Gagliardi M, et al. Polyphosphate-based hydrogels as drug-loaded wound dressing: An in vitro study. ACS Appl Polym Mater  2022; 4(4): 2871-9.
 [http://dx.doi.org/10.1021/acsapm.1c01533]

[104]
Hu F, Gao Q, Liu J, et al. Smart microneedle patches for wound healing and management. J Mater Chem B Mater Biol Med  2023; 11(13): 2830-51.
 [http://dx.doi.org/10.1039/D2TB02596E] [PMID: 36916631]

[105]
Yang X, Zhang C, Deng D, Gu Y, Wang H, Zhong Q. Multiple stimuli-responsive MXene-based hydrogel as intelligent drug delivery carriers for deep chronic wound healing. Small  2022; 18(5): 2104368.
 [http://dx.doi.org/10.1002/smll.202104368] [PMID: 34821453]

[106]
Deng M, Wu Y, Ren Y, et al. Clickable and smart drug delivery vehicles accelerate the healing of infected diabetic wounds. J Control Release  2022; 350: 613-29.
 [http://dx.doi.org/10.1016/j.jconrel.2022.08.053] [PMID: 36058354]

[107]
Mai B, Jia M, Liu S, et al. Wang, Smart hydrogel-based dvdms/bfgf nanohybrids for antibacterial phototherapy with multiple damaging sites and accelerated wound healing. ACS Appl Mater Interfaces  2020; 12(9): 10156-69.
 [http://dx.doi.org/10.1021/acsami.0c00298] [PMID: 32027477]

[108]
Zhu J, Li F, Wang X, Yu J, Wu D. Hyaluronic acid and polyethylene glycol hybrid hydrogel encapsulating nanogel with hemostasis and sustainable antibacterial property for wound healing. ACS Appl Mater Interfaces  2018; 10(16): 13304-16.
 [http://dx.doi.org/10.1021/acsami.7b18927] [PMID: 29607644]

[109]
Homann HH, Rosbach O, Moll W, et al. A liposome hydrogel with polyvinyl-pyrrolidone iodine in the local treatment of partial-thickness burn wounds. Ann Plast Surg  2007; 59(4): 423-7.
 [http://dx.doi.org/10.1097/SAP.0b013e3180326fcf] [PMID: 17901735]

[110]
Vogt PM, Hauser J, Rossbach O, et al. Polyvinyl pyrrolidone-iodine liposome hydrogel improves epithelialization by combining moisture and antisepis. A new concept in wound therapy. Wound Repair Regen  2001; 9(2): 116-22.
 [http://dx.doi.org/10.1046/j.1524-475x.2001.00116.x] [PMID: 11350649]

[111]
Ternullo S, Schulte Werning LV, Holsæter AM, Škalko-Basnet N. Curcumin-in-deformable liposomes-in-chitosan-hydrogel as a novel wound dressing. Pharmaceutics  2019; 12(1): 8.
 [http://dx.doi.org/10.3390/pharmaceutics12010008] [PMID: 31861794]

[112]
Liu M, Chen W, Zhang X, et al. Improved surface adhesion and wound healing effect of madecassoside liposomes modified by temperature-responsive PEG-PCL-PEG copolymers. Eur J Pharm Sci  2020; 151: 105373.
 [http://dx.doi.org/10.1016/j.ejps.2020.105373] [PMID: 32450220]

[113]
Cardoso-Daodu IM, Ilomuanya MO, Azubuike CP. Development of curcumin-loaded liposomes in lysine-collagen hydrogel for surgical wound healing. Beni Suef Univ J Basic Appl Sci  2022; 11(1): 100.
 [http://dx.doi.org/10.1186/s43088-022-00284-2]

[114]
Yu JR, Janssen M, Liang BJ, Huang HC, Fisher JP. A liposome/gelatin methacrylate nanocomposite hydrogel system for delivery of stromal cell-derived factor-1α and stimulation of cell migration. Acta Biomater  2020; 108: 67-76.
 [http://dx.doi.org/10.1016/j.actbio.2020.03.015] [PMID: 32194261]

[115]
Yu JR, Varrey P, Liang BJ, Huang HC, Fisher JP. Liposomal SDF-1 alpha delivery in nanocomposite hydrogels promotes macrophage phenotype changes and skin tissue regeneration. ACS Biomater Sci Eng  2021; 7(11): 5230-41.
 [http://dx.doi.org/10.1021/acsbiomaterials.1c01140] [PMID: 34699182]

[116]
Bahramizadeh M, Bahramizadeh M, Kiafar B, et al. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. Int J Pharm  2019; 569: 118623.
 [http://dx.doi.org/10.1016/j.ijpharm.2019.118623] [PMID: 31419462]

[117]
Saka R, Jain H, Kommineni N, Chella N, Khan W. Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice. J Drug Deliv Sci Technol  2020; 58: 101691.
 [http://dx.doi.org/10.1016/j.jddst.2020.101691]

[118]
Pradhan M, Alexander A, Singh MR, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother  2018; 107: 447-63.
 [http://dx.doi.org/10.1016/j.biopha.2018.07.156] [PMID: 30103117]

[119]
Tripathi P, Kumar A, Jain PK, Patel JR. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis. Int J Biol Macromol  2018; 120(Pt A): 1322-34.
 [http://dx.doi.org/10.1016/j.ijbiomac.2018.08.136] [PMID: 30171962]

[120]
Jyothi SL, Krishna KL, Ameena Shirin VK, Sankar R, Pramod K, Gangadharappa HV. Drug delivery systems for the treatment of psoriasis: Current status and prospects. J Drug Deliv Sci Technol  2021; 62: 102364.
 [http://dx.doi.org/10.1016/j.jddst.2021.102364]

[121]
Filippone A, Consoli GML, Granata G, et al. Topical delivery of curcumin by choline-calix[4]arene-based nanohydrogel improves its therapeutic effect on a psoriasis mouse model. Int J Mol Sci  2020; 21(14): 5053.
 [http://dx.doi.org/10.3390/ijms21145053] [PMID: 32708987]

[122]
Armstrong AW, Read C. Pathophysiology, Clinical presentation, and treatment of psoriasis: A review. JAMA  2020; 323(19): 1945-60.
 [http://dx.doi.org/10.1001/jama.2020.4006] [PMID: 32427307]

[123]
Korman NJ. Management of psoriasis as a systemic disease: What is the evidence? Br J Dermatol  2020; 182(4): 840-8.
 [http://dx.doi.org/10.1111/bjd.18245] [PMID: 31225638]

[124]
Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: From keratinocyte perspective. Cell Death Dis  2022; 13(1): 81.
 [http://dx.doi.org/10.1038/s41419-022-04523-3] [PMID: 35075118]

[125]
Aziz Hazari S, Kaur H, Karwasra R, Abourehab MAS, Ali Khan A, Kesharwani P. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis. Int J Pharm  2023; 638: 122938.
 [http://dx.doi.org/10.1016/j.ijpharm.2023.122938] [PMID: 37031809]

[126]
Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: Current issues, mechanistic insight and novel delivery approaches. J Control Release  2013; 170(3): 380-95.
 [http://dx.doi.org/10.1016/j.jconrel.2013.05.020] [PMID: 23770117]

[127]
An E, Jeong CB, Cha C, et al. Fabrication of microgel-in-liposome particles with improved water retention. Langmuir  2012; 28(9): 4095-101.
 [http://dx.doi.org/10.1021/la2046349] [PMID: 22296414]

[128]
Xi L, Lin Z, Qiu F, et al. Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment. Acta Pharm Sin B  2022; 12(1): 339-52.
 [http://dx.doi.org/10.1016/j.apsb.2021.07.019] [PMID: 35127390]

[129]
Jain A, Doppalapudi S, Domb AJ, Khan W. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. J Control Release  2016; 243: 132-45.
 [http://dx.doi.org/10.1016/j.jconrel.2016.10.004] [PMID: 27725194]

[130]
Bieber T, Simpson EL, Silverberg JI, et al. Abrocitinib versus placebo or dupilumab for atopic dermatitis. N Engl J Med  2021; 384(12): 1101-12.
 [http://dx.doi.org/10.1056/NEJMoa2019380] [PMID: 33761207]

[131]
Silverberg JI, Guttman-Yassky E, Thaçi D, et al. Two phase 3 trials of lebrikizumab for moderate-to-severe atopic dermatitis. N Engl J Med  2023; 388(12): 1080-91.
 [http://dx.doi.org/10.1056/NEJMoa2206714] [PMID: 36920778]

[132]
Nakatsuji T, Hata TR, Tong Y, et al. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med  2021; 27(4): 700-9.
 [http://dx.doi.org/10.1038/s41591-021-01256-2] [PMID: 33619370]

[133]
Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in America study: A cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the us adult population. J Invest Dermatol  2019; 139(3): 583-90.
 [http://dx.doi.org/10.1016/j.jid.2018.08.028] [PMID: 30389491]

[134]
Kabashima K, Matsumura T, Komazaki H, Kawashima M. Trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med  2020; 383(2): 141-50.
 [http://dx.doi.org/10.1056/NEJMoa1917006] [PMID: 32640132]

[135]
Silverberg JI, Gelfand JM, Margolis DJ, et al. Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. Ann Allergy Asthma Immunol  2018; 121(5): 604-612.e3.
 [http://dx.doi.org/10.1016/j.anai.2018.07.042] [PMID: 30092266]

[136]
Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol  2019; 123(2): 144-51.
 [http://dx.doi.org/10.1016/j.anai.2019.04.020] [PMID: 31034875]

[137]
Hill DA, Spergel JM. The atopic march. Ann Allergy Asthma Immunol  2018; 120(2): 131-7.
 [http://dx.doi.org/10.1016/j.anai.2017.10.037] [PMID: 29413336]

[138]
Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc  2019; 40(2): 84-92.
 [http://dx.doi.org/10.2500/aap.2019.40.4202] [PMID: 30819278]

[139]
Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J Allergy Clin Immunol  2016; 138(2): 350-358.e1.
 [http://dx.doi.org/10.1016/j.jaci.2016.06.002] [PMID: 27497277]

[140]
Bin L, Leung DYM. Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol  2016; 12(1): 52.
 [http://dx.doi.org/10.1186/s13223-016-0158-5] [PMID: 27777593]

[141]
Yuki T, Tobiishi M, Kusaka-Kikushima A, Ota Y, Tokura Y. Impaired Tight junctions in atopic dermatitis skin and in a skin-equivalent model treated with interleukin-17. PLoS One  2016; 11(9): e0161759.
 [http://dx.doi.org/10.1371/journal.pone.0161759] [PMID: 27588419]

[142]
Chittock J, Cooke A, Lavender T, et al. Development of stratum corneum chymotrypsin-like protease activity and natural moisturizing factors from birth to 4 weeks of age compared with adults. Br J Dermatol  2016; 175(4): 713-20.
 [http://dx.doi.org/10.1111/bjd.14568] [PMID: 26994359]

[143]
Lee YL, Yen JJY, Hsu LC, et al. Association of STAT6 genetic variants with childhood atopic dermatitis in Taiwanese population. J Dermatol Sci  2015; 79(3): 222-8.
 [http://dx.doi.org/10.1016/j.jdermsci.2015.05.006] [PMID: 26048407]

[144]
Salpietro C, Rigoli L, Del Giudice MM, et al. TLR2 and TLR4 gene polymorphisms and atopic dermatitis in Italian children: A multicenter study. Int J Immunopathol Pharmacol  2011; 24(4_suppl): 33-40.
 [http://dx.doi.org/10.1177/03946320110240S408] [PMID: 22032785]

[145]
Eichenfield LF, Call RS, Forsha DW, et al. Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. J Am Acad Dermatol  2017; 77(4): 641-649.e5.
 [http://dx.doi.org/10.1016/j.jaad.2017.06.010] [PMID: 28823881]

[146]
Gooderham M, Kircik L, Zirwas M, et al. The safety and efficacy of roflumilast cream 0.15% and 0.05% in patients with atopic dermatitis: Randomized, double-blind, phase 2 proof of concept study. J Drugs Dermatol  2023; 22(2): 139-47.
 [http://dx.doi.org/10.36849/JDD.7295] [PMID: 36745371]

[147]
Niemeyer-van der Kolk T, van der Wall H, Hogendoorn GK, et al. Pharmacodynamic effects of topical omiganan in patients with mild to moderate atopic dermatitis in a randomized, placebo-controlled, phase II trial. Clin Transl Sci  2020; 13(5): 994-1003.
 [http://dx.doi.org/10.1111/cts.12792] [PMID: 32315497]

[148]
Lee YI, Lee SG, Kim J, Choi S, Jung I, Lee JH. Proteoglycan combined with hyaluronic acid and hydrolyzed collagen restores the skin barrier in mild atopic dermatitis and dry, eczema-prone skin: A pilot study. Int J Mol Sci  2021; 22(19): 10189.
 [http://dx.doi.org/10.3390/ijms221910189] [PMID: 34638528]

[149]
Ibaraki H, Kanazawa T, Kurano T, Oogi C, Takashima Y, Seta Y. Anti-RelA siRNA-encapsulated flexible liposome with tight junction-opening peptide as a non-invasive topical therapeutic for atopic dermatitis. Biol Pharm Bull  2019; 42(7): 1216-25.
 [http://dx.doi.org/10.1248/bpb.b19-00259] [PMID: 31257297]

[150]
Wang Y, Yue Y, Jia R, et al. Design and evaluation of paeonol-loaded liposomes in thermoreversible gels for atopic dermatitis. Gels  2023; 9(3): 198.
 [http://dx.doi.org/10.3390/gels9030198] [PMID: 36975647]

[151]
Hu YS, Han X, Yu PJ, Jiao MM, Liu XH, Shi JB. Novel paeonol derivatives: Design, synthesis and anti-inflammatory activity in vitro and in vivo. Bioorg Chem  2020; 98: 103735.
 [http://dx.doi.org/10.1016/j.bioorg.2020.103735] [PMID: 32171986]

[152]
Tang H, Yang D, Zhu L, et al. Paeonol interferes with quorum-sensing in Pseudomonas aeruginosa and modulates inflammatory responses in vitro and in vivo. Front Immunol  2022; 13: 896874.
 [http://dx.doi.org/10.3389/fimmu.2022.896874] [PMID: 35686124]

[153]
Guo S, Zhang Q. Paeonol protects melanocytes against hydrogen peroxide-induced oxidative stress through activation of Nrf2 signaling pathway. Drug Dev Res  2021; 82(6): 861-9.
 [http://dx.doi.org/10.1002/ddr.21793] [PMID: 33491230]

[154]
Shutova MS, Boehncke WH. Mechanotransduction in skin inflammation. Cells  2022; 11(13): 2026.
 [http://dx.doi.org/10.3390/cells11132026] [PMID: 35805110]

[155]
Jia Y, Hu J, An K, et al. Hydrogel dressing integrating FAK inhibition and ROS scavenging for mechano-chemical treatment of atopic dermatitis. Nat Commun  2023; 14(1): 2478.
 [http://dx.doi.org/10.1038/s41467-023-38209-x] [PMID: 37120459]

[156]
Kharwade R, Ali N, Gangane P, et al. DOE-assisted formulation, optimization, and characterization of tioconazole-loaded transferosomal hydrogel for the effective treatment of atopic dermatitis: In vitro and in vivo evaluation. Gels  2023; 9(4): 303.
 [http://dx.doi.org/10.3390/gels9040303] [PMID: 37102915]

[157]
Demartis S, Rassu G, Murgia S, Casula L, Giunchedi P, Gavini E. Improving dermal delivery of rose bengal by deformable lipid nanovesicles for topical treatment of melanoma. Mol Pharm  2021; 18(11): 4046-57.
 [http://dx.doi.org/10.1021/acs.molpharmaceut.1c00468] [PMID: 34554752]

[158]
Mirzavi F, Barati M, Soleimani A, Vakili-Ghartavol R, Jaafari MR, Soukhtanloo M. A review on liposome-based therapeutic approaches against malignant melanoma. Int J Pharm  2021; 599: 120413.
 [http://dx.doi.org/10.1016/j.ijpharm.2021.120413] [PMID: 33667562]

[159]
Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. J Control Release  2016; 228: 150-8.
 [http://dx.doi.org/10.1016/j.jconrel.2016.03.010] [PMID: 26965957]

[160]
Sahu P, Kashaw SK, Jain S, Sau S, Iyer AK. Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies. J Control Release  2017; 253: 122-36.
 [http://dx.doi.org/10.1016/j.jconrel.2017.03.023] [PMID: 28322977]

[161]
López-Noriega A, Hastings CL, Ozbakir B, et al. Hyperthermia-induced drug delivery from thermosensitive liposomes encapsulated in an injectable hydrogel for local chemotherapy. Adv Healthc Mater  2014; 3(6): 854-9.
 [http://dx.doi.org/10.1002/adhm.201300649] [PMID: 24436226]

[162]
Ren S, Dai Y, Li C, et al. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin. Eur J Pharm Sci  2016; 92: 137-45.
 [http://dx.doi.org/10.1016/j.ejps.2016.07.002] [PMID: 27388491]

[163]
Wang W, Zhang P, Shan W, Gao J, Liang W. A novel chitosan-based thermosensitive hydrogel containing doxorubicin liposomes for topical cancer therapy. J Biomater Sci Polym Ed  2013; 24(14): 1649-59.
 [http://dx.doi.org/10.1080/09205063.2013.789357] [PMID: 23607789]

[164]
Cao D, Zhang X, Akabar M, et al. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer. Artif Cells Nanomed Biotechnol  2019; 47(1): 181-91.
 [http://dx.doi.org/10.1080/21691401.2018.1548470] [PMID: 30686051]

[165]
Basu K, Baral A, Basak S, et al. Peptide based hydrogels for cancer drug release: Modulation of stiffness, drug release and proteolytic stability of hydrogels by incorporating D-amino acid residue(s). Chem Commun  2016; 52(28): 5045-8.
 [http://dx.doi.org/10.1039/C6CC01744D] [PMID: 26987440]

[166]
Li R, Lyu Y, Luo S, et al. Fabrication of a multi-level drug release platform with liposomes, chitooligosaccharides, phospholipids and injectable chitosan hydrogel to enhance anti-tumor effectiveness. Carbohydr Polym  2021; 269: 118322.
 [http://dx.doi.org/10.1016/j.carbpol.2021.118322] [PMID: 34294334]

[167]
Tsai HC, Chou HY, Chuang SH, et al. Preparation of immunotherapy liposomal-loaded thermal-responsive hydrogel carrier in the local treatment of breast cancer. Polymers  2019; 11(10): 1592.
 [http://dx.doi.org/10.3390/polym11101592] [PMID: 31569466]

[168]
Chen G, Ullah A, Xu G, et al. Topically applied liposome-in-hydrogels for systematically targeted tumor photothermal therapy. Drug Deliv  2021; 28(1): 1923-31.
 [http://dx.doi.org/10.1080/10717544.2021.1974607] [PMID: 34550040]

[169]
Kong Y, Dai Y, Qi D, et al. Injectable and Thermosensitive liposomal hydrogels for nir-ii light-triggered photothermal-chemo therapy of pancreatic cancer. ACS Appl Bio Mater  2021; 4(10): 7595-604.
 [http://dx.doi.org/10.1021/acsabm.1c00864] [PMID: 35006703]

[170]
Bai R, Deng X, Wu Q, Cao X, Ye T, Wang S. Liposome-loaded thermo-sensitive hydrogel for stabilization of SN-38 via intratumoral injection: Optimization, characterization, and antitumor activity. Pharm Dev Technol  2018; 23(1): 106-15.
 [http://dx.doi.org/10.1080/10837450.2017.1391287] [PMID: 29019266]

[171]
Jiang T, Wang T, Li T, et al. Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma. ACS Nano  2018; 12(10): 9693-701.
 [http://dx.doi.org/10.1021/acsnano.8b03800] [PMID: 30183253]
Cite As
Current Pharmaceutical Design

Localized Delivery of Bioactives using Structured Liposomal Gels

Abstract
